Fluvoxamine alleviates ER stress via induction of Sigma-1 receptor

Cell Death and Disease

Volumn 5, Issue 7, 2014, Pages

  Omi, T ^a,b   Tanimukai, H ^a   Kanayama, D ^a   Sakagami, Y ^b   Tagami, S ^a   Okochi, M ^a   Morihara, T ^a   Sato, M ^a   Yanagida, K ^a   Kitasyoji, A ^c   Hara, H ^c   Imaizumi, K ^d   Maurice, T ^e   Chevallier, N ^e   Marchal, S ^e   Takeda, M ^a   Kudo, T ^f  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA GENERAL MEDICAL CENTER   (Japan)

^c GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

^d HIROSHIMA UNIVERSITY   (Japan)

^e UNIV MONTPELLIER   (France)

^f OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 4; FLUVOXAMINE; SIGMA 1 OPIATE RECEPTOR; SIGMA OPIATE RECEPTOR; SIGMA-1 RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BINDING AFFINITY; BRAIN INFARCTION; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG RECEPTOR BINDING; ENDOPLASMIC RETICULUM STRESS; HUMAN; HUMAN CELL; MALE; MOUSE; NERVE CELL NECROSIS; NEUROBLASTOMA CELL; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; CYTOLOGY; DRUG EFFECTS; GENETICS; HEK293 CELL LINE; KNOCKOUT MOUSE; METABOLISM; NERVE CELL; SIGNAL TRANSDUCTION; UPREGULATION;

ACTIVATING TRANSCRIPTION FACTOR 4; ANIMALS; APOPTOSIS; ENDOPLASMIC RETICULUM STRESS; FLUVOXAMINE; HEK293 CELLS; HUMANS; MALE; MICE; MICE, KNOCKOUT; NEURONS; RECEPTORS, SIGMA; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84905513093     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2014.301     Document Type: Article

References (34)

1. Hayashi T, Su TP. Sigma-1receptor ligands: Potential in the treatment of neuropsychiatric disorders. CNS Drugs 2004; 18: 269-284
2. Hayashi T, Su TP. Sigma-1 receptors: Evolution of the concept in neuropsychopharmacology. Curr Neuropharmacol 2005; 3: 267-280
3. Hayashi T, Maurice T, Su TP. Ca2+ signaling via sigma-1 receptors: Novel regulatory mechanism affecting intracellular Ca2+concentration. J Pharmacol Exp Ther 2000; 293: 788-798
4. Hayashi T, Su TP. Regulating ankyrin dynamics: Roles of sigma-1 receptors. Proc Natl Acad Sci USA 2001; 98: 491-496
5. Weissman AD, Casanova MF, Kleinman JE, London ED, De Souza EB. Selective loss of cerebral cortical sigma, but not PCP binding sites in schizophrenia. Biol Psychiatry 1991; 29: 41-54
6. Sabino V, Cottone P, Parylak SL, Steardo L, Zorrilla EP. Sigma-1 receptor knockout mice display a depressive-Like phenotype. Behav Brain Res 2009; 198: 472-476
7. Hayashi T, Su TP. The sigma receptor: Evolution of the concept in neuropsychopharmacology. Curr Neuropharmacol 2005; 3: 267-280
8. Hayashi T, Tsai SY, Mori T, Fujimoto M, Su TP. Targeting ligand-Operated chaperone sigma-1 receptors in the treatment of neuropsychiatric disorders. Expert Opin Ther Targets 2011; 15: 557-577
9. Mitsuda T, Omi T, Tanimukai H, Sakagami Y, Kudo T, Takeda M. Sigma-1Rs are upregulated via PERK/eIF2alpha/ATF4 pathway and execute protective function in ER stress. Biochem Biophys Res Commun 2011; 415: 519-525
10. Narita N, Hashimoto K, Tomitaka S, Minabe Y. Interactions of selective serotonin reuptake inhibitors with subtypes of sigma receptors in rat brain. Eur J Pharmacol 1996; 307: 117-119
11. Sidrauski C, Chapman R, Walter P. The unfolded protein response: An intracellular signaling pathway with many surprising features. Trends Cell Biol 1998; 8: 245-249
12. Lu PD, Harding HP, Ron D. Translation reinitiation at alternative open readingframes regulates gene expression in an integrated stress response. J Cell Biol 2004; 167: 27-33
13. Vattem KM, Wek RC. Reinitiation involving upstream ORFs regulates ATF4mRNA translation in mammalian cells. Proc Natl Acad Sci USA 2004; 101: 11269-11274
14. DeGracia DJ, Montie HL. Cerebral ischemia and the unfolded protein response. J Clin Invest 2004; 91: 1-8
15. Hara H, Huang PL, Panahian N, Fishman MC, Moskowitz MA. Reduced brainedema and infarction volume in mice lacking the neuronal isoform ofnitric oxide synthase after transient MCA occlusion. J Cereb Blood Flow Metab 1996; 16: 605-611
16. Hara H, Friedlander RM, Gagliardini V, Ayata C, Fink K, Moskowitz MA et al. Inhibition of interleukin 1b converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. Proc. Natl Acad Sci USA 1997; 94: 2007-2012
17. Hitomi J, Katayama T, Eguchi Y, Kudo T, Taniguchi M, Imaizumi K et al. Involvement of caspase-4 in endoplasmic reticulum stress-induced apoptosis and A b-induced cell death. J Cell Biol 2004; 165: 347-356
18. Nakagawa T, Zhu H, Morishima N, Li E, Xu J, Yuan J et al. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature 2000; 403: 98-103
19. Nishitoh H, Matsuzawa A, Tobiume K, Saegusa K, Takeda K, Ichijo H et al. ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats. Genes Dev 2002; 16: 1345-1355
20. Kudo T, Kanemoto S, Hara H, Morimoto N, Imaizumi K, Takeda M et al. A molecular chaper one inducer protects neurons from ER stress. Cell Death Differ 2008; 15: 364-375
21. Kimball SR, Fabian JR, Pavitt GD, Hinnebusch AG, Jefferson LS. Regulation of Guanine Nucleotide Exchange through Phosphorylation of Eukaryotic Initiation Factor eIF2: ROLE OF THE a-and d-SUBUNITS OF eIF2B. J Biol Chem 1998; 272: 21661-21664
22. Ishiguro H, Ohtsuki T, Toru M, Itokawa M, Aoki J, Arinami T et al. Association between polymorphisms in the type 1 sigma receptor gene and schizophrenia. Neurosci Lett 1998; 257: 45-46
23. Qu M, Tang F, Wang L, Yan H, Han Y, Zhang D et al. Associations of ATF4 gene polymorphisms with schizophrenia in male patients. Am J Med Genet B Neuropsychiatr Genet 2008; 147B: 732-736
24. Niitsu T, Fujisaki M, Shiina A, Yoshida T, Hasegawa T, Iyo M et al. A randomized, doubleblind, placebo-controlled trial of fluvoxamine in patients with schizophrenia: A preliminary study. J Clin Psychopharmacol 2012; 32: 593-601
25. Takebayashi M, Hayashi T, Su TP. Nerve growth factor-induced neurite sprouting in PC12 cells involved s-1 receptors: Implications for antidepressants. J Pharmacol Exp Ther 2002; 303: 1227-1237
26. Hayashi A, Kasahara T, Iwamoto K, Ishiwata M, Kametani M, Kato T et al. The role of brainderived neurotrophic factor (BDNF)-Induced XBP1 splicing during brain development. J Biol Chem 2007; 282: 34525-34534
27. -/- mice reveals a role for translational control in secretory cell survival. Mol Cell 2001; 7: 1153-1163
28. Ozawa K, Tsukamoto Y, Hori O, Kitao Y, Yanagi H, Ogawa S et al. Regulation of tumor angiogenesis by oxygen-regulated protein 150, an inducible endoplasmic reticulum chaperone. Cancer Res 2001; 61: 4206-4213
29. Martindale JJ, Fernandez R, Thuerauf D, Whittaker R, Gude N, Glembotski CC et al. Endoplasmic reticulum stress gene induction and protection fromischemia/reperfusion injury in the hearts of transgenic mice with a tamoxifen-regulated form of ATF6. Circ Res 2006; 98: 1186-1193
30. Imai Y, Soda M, Hatakeyama S, Akagi T, Hashikawa T, Takahashi R et al. CHIP is associated with Parkin, a gene responsible for familial Parkinson's disease, and enhances its ubiquitin ligase activity. Mol Cell 2002; 10: 55-67
31. Katayama T, Imaizumi K, Sato N, Miyoshi K, Kudo T, Tohyama M et al. Presenilin-1 mutations downregulate the signaling pathway of the unfolded-protein response. Nat Cell Biol 1999; 8: 479-485
32. Katayama T, Imaizumi K, Honda A, Yoneda T, Kudo T, Tohyama M,A et al. Disturbed activation of endoplasmic reticulum stress transducers by familial Alzheimer's diseaselinked presenilin 1 mutations. J Biol Chem 2001; 276: 43446-43454
33. Ishiwata K, Oda K, Sakata M, Kimura Y, Kawamura K, Ishii K et al. A feasibility study of [11C]SA4503-PET for evaluating sigma-1 receptor occupancy by neuroleptics: the binding of haloperidol to sigma-1 and dopamine D2-Like receptors. Ann Nucl Med 2006; 20: 569-573
34. Mitsuda T, Hayakawa Y, Itoh M, Ohta K, Nakagawa T. ATF4 regulates gamma-Secretase activity during amino acid imbalance. Biochem Biophys. Res Commun 2007; 352: 722-727